John E. Voris

Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA.

Gentiae Clinical Research, Inc. provides cardiovascular laboratory services to the pharmaceutical, biotechnology, and medical device companies. It provides cardiac safety monitoring, core laboratory, data management, and global logistic services to support clinical trials. The company was founded in 2001 and is headquartered in San Bruno, CA.

Epocrates LLC provides clinical tools and solutions. The firm provides the healthcare industry, primarily pharmaceutical companies, and opportunities to engage with its user network through delivery of targeted information and to conduct market research. The company was founded by Richard Fiedotin and Jeff Tangney on August 1998 and is headquartered in San Mateo, CA.

Regenesis Biomedical, Inc. operates as a medical technology company which designs, manufactures, and markets energy-based medical products and services. The firm offers Provant therapy system for the palliative treatment of post-operative pain and edema in superficial soft tissue. The company was founded by Frank R. George and Mary C. Ritz in 1997 and is headquartered in Scottsdale, AZ.

American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA.